Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnerships
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnerships
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > Partnerships > ECL > The past, present and future of the European Code against Cancer (ECAC)

The past, present and future of the European Code against Cancer (ECAC)

  • 30 August 2022
  • ECL
The past, present and future of the European Code against Cancer (ECAC)
Total
0
Shares
0
0
0
0
0

It seems that hardly a week goes by without some media outlet reporting anxiously on the latest thing that has been linked to cancer. The average person would be forgiven for thinking that everything can cause cancer. Thankfully, far-sighted experts broughttogether by the European Commission four decades ago developed a framework to inform the public of the key things they needed to know to prevent cancer.

The European Code against Cancer (ECAC) informs people about actions they can take to reduce their cancer risk. An initiativeof the European Commission, the scientific basis for the ECAC is provided by the International Agency for Research on Cancer (WHO/IARC), marking it out as the definitive tool for cancer prevention in Europe.

The Past

Right from the start, cancer leagues have been the early adopters and primary promoters of the ECAC.

Leagues have used it to inform targeted communication to specific groups, develop health promotion interventions, and support policy recommendations at the governmental level. At the Association of European Cancer Leagues (ECL), all of
our cancer prevention work has been based on the evidence provided by each edition of ECAC.

Since 2014, ECL has acted as ECAC’s custodian, having invested considerable resources to support member leagues to use ECAC and apply its evidence to promote cancer prevention at the national and local levels. We have also empowered and trained dozens of Youth Ambassadors to disseminate ECAC amongst their peers and the wider public.

The Present

The current edition of ECAC consists of 12 simple-tounderstand messages complemented by:

  • Fourteen scientific publications describing the methodology to update ECAC and evidence for eachmessage
  • an extensive online Q&A section
  • Two sets of self-paced, multilingual e-learning modules about ECAC (available in English and French and soon in German, Hungarian, Spanish and Polish)

We encourage everyone to make use of these free resources and complete the ECAC e-learning modules to gain a certification as an ECAC promoter!

The Future

Europe’s Beating Cancer Plan demonstrates the commitment of the European Union to diminishing the negative impact of cancer on society. A key priority of the plan is the commitment to update the ECAC.

The future 5th edition represents a golden opportunity to build on past successes by expanding the scope of ECAC to incorporate new tools and materials to aid implementation and dissemination. To do so, a permanent mechanism to update the ECAC in the long term is needed.

ECL is appealing for the establishment of a robust governance model for the ECAC and calls on all stakeholders to become active promoters.

So why not join cancer leagues, WHO/IARC and the EU institutions in amplifying ECAC and, together, we can step-up cancer prevention in Europe!

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
External Contributor

You May Also Like
View Post
  • News

Improving outcomes in elderly patients taking multiple medications

  • Janet Fricker
  • 24 March 2023
View Post
  • News

Localised prostate cancer: active monitoring offers valid option

  • Janet Fricker
  • 24 March 2023
View Post
  • Articles
  • Delivery of Care

‘Fragile’ cancer patients hit by Turkish earthquake need urgent support

  • Marwa Koçak
  • 22 March 2023
View Post
  • Articles
  • Delivery of Care

Expert cancer surgery: could VR help speed up and standardise training?

  • Simon Crompton
  • 22 March 2023
View Post
  • Articles
  • Medicine

Immunotherapy: three studies point to potential strategies to improve response

  • Janet Fricker
  • 10 March 2023
View Post
  • Articles
  • Biology basic

A blood test for early detection of any cancer: What’s the ideal? Are we getting there?

  • Rachel Brazil
  • 10 March 2023
View Post
  • News

Radiotherapy can be safely omitted in older women with low-risk breast cancer

  • Janet Fricker
  • 10 March 2023
View Post
  • News

Plant-based diets cut risk of prostate cancer progression and recurrence by over 50%

  • Janet Fricker
  • 9 March 2023
search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Improving outcomes in elderly patients taking multiple medications
    • 24 March 2023
  • Localised prostate cancer: active monitoring offers valid option
    • 24 March 2023
  • Radiotherapy can be safely omitted in older women with low-risk breast cancer
    • 10 March 2023
  • Plant-based diets cut risk of prostate cancer progression and recurrence by over 50%
    • 9 March 2023
  • A blood test to recognize prostate cancer
    New prostate cancer blood test combining PSA with epigenetic test could reduce biopsies
    • 23 February 2023
Article
  • ‘Fragile’ cancer patients hit by Turkish earthquake need urgent support
    • 22 March 2023
  • Expert cancer surgery: could VR help speed up and standardise training?
    • 22 March 2023
  • Immunotherapy: three studies point to potential strategies to improve response
    • 10 March 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • AI in Surgery
    • 8 March 2023
  • COVID and haematological malignancies
    • 28 February 2023
  • Telemedicine Rehabilitation in the Cancer Care Continuum
    • 24 February 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnerships
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.